115794-30-4 Usage
Stereochemistry
(1S,2S)indicates the specific spatial arrangement of the atoms in the molecule.
Class
Cycloalkane carboxylic acids
Carboxylic Acid Ester
The presence of the ester group (-COOCH3) in the molecule.
Cycloalkane
The presence of a cyclic carbon structure.
Keto Group
The presence of a carbonyl group (C=O) in the 4-position.
Chemical Industry
Used as a building block for the synthesis of various compounds.
Pharmaceutical Industry
Important in drug discovery and development due to its specific stereochemistry.
Agrochemicals
Used in the synthesis of compounds for agricultural applications.
Specialty Chemicals
Employed in the production of specialized chemicals.
Biological Activity
The specific stereochemistry of the compound ensures its biological activity, making it a valuable molecule in the development of pharmaceuticals and other biologically active compounds.
Chirality
The compound is chiral, meaning it has a non-superimposable mirror image (enantiomer). The (1S,2S)designation indicates the specific configuration of the chiral centers in the molecule.
Molecular Weight
Approximately 170.16 g/mol (calculated from the molecular formula)
Solubility
The compound is likely to be soluble in organic solvents such as ethanol, methanol, and acetone, due to its ester functional group. However, solubility in water may be limited.
Check Digit Verification of cas no
The CAS Registry Mumber 115794-30-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,1,5,7,9 and 4 respectively; the second part has 2 digits, 3 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 115794-30:
(8*1)+(7*1)+(6*5)+(5*7)+(4*9)+(3*4)+(2*3)+(1*0)=134
134 % 10 = 4
So 115794-30-4 is a valid CAS Registry Number.
115794-30-4Relevant articles and documents
PROCESSES AND INTERMEDIATES FOR PREPARING A MACROCYCLIC PROTEASE INHIBITOR OF HCV
-
Page/Page column 23; 24, (2017/01/09)
Disclosed is a process for the preparation of certain intermediates, e.g. those in the scheme below: which intermediates and processes are useful in the preparation of the macrocyclic HVC inhibitor Simeprevir.
The Synthesis of Novel Trans-Oxabicyclo[3,3,0]octane Systems as Potential Inhibitors of HIV Protease
Mahler, Mikael E.,Palmer, Michael J.
, p. 193 - 194 (2007/10/03)
The novel trans-3-oxabicyclo[3,3.0]octan-7-one system has been prepared by intramolecular ring closure of the corresponding cyclopentane diol. Peralkylation and benzylidene substitution of the octanone has allowed the preparation of tetra-alkylated potential inhibitors of HIV protease. Weak activity against HIV protease (IC50's 70-100μM) was observed.
SYNTHESIS OF RING-ENLARGED CYCLOBUT-A AND CYCLOBUT-G ANALOGUES AS HIV INHIBITORS. PART 4
Boumchita, Hassane,Legraverend, Michel,Bisagni, Emile
, p. 1785 - 1792 (2007/10/02)
Two ring-expanded analogues (compounds 13 and 14) of the anti-HIV agents Cyclobut-A and Cyclobut-G are described.They were synthesized from trans-3,4-bis(hydroxymethyl)cyclobutylamine which was obtained from threo-3,4-bis(methoxycarbonyl)hexane dioic acid.Neither compound (13,14) was able to provide protection to CEM cells against HIV-1-infection.